Source: The Hindu Business Line

Nesher: Nesher Pharma gets USFDA nod to market ADHD tablets

Cadila Healthcare today said that Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final approval from the US health regulator to market Dextroamphetamine Sulfate and A...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100